ENDRA Life Sciences (NDRA) Competitors $4.33 -0.22 (-4.84%) Closing price 02/21/2025 03:46 PM EasternExtended Trading$4.67 +0.34 (+7.94%) As of 02/21/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends NDRA vs. BTCY, POAI, AEMD, INBS, NURO, MHUA, CUTR, QTI, ICU, and PAVMShould you be buying ENDRA Life Sciences stock or one of its competitors? The main competitors of ENDRA Life Sciences include Biotricity (BTCY), Predictive Oncology (POAI), Aethlon Medical (AEMD), Intelligent Bio Solutions (INBS), NeuroMetrix (NURO), Meihua International Medical Technologies (MHUA), Cutera (CUTR), QT Imaging (QTI), SeaStar Medical (ICU), and PAVmed (PAVM). These companies are all part of the "medical equipment" industry. ENDRA Life Sciences vs. Biotricity Predictive Oncology Aethlon Medical Intelligent Bio Solutions NeuroMetrix Meihua International Medical Technologies Cutera QT Imaging SeaStar Medical PAVmed ENDRA Life Sciences (NASDAQ:NDRA) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations, community ranking and media sentiment. Does the media favor NDRA or BTCY? In the previous week, Biotricity had 5 more articles in the media than ENDRA Life Sciences. MarketBeat recorded 5 mentions for Biotricity and 0 mentions for ENDRA Life Sciences. Biotricity's average media sentiment score of 0.15 beat ENDRA Life Sciences' score of 0.00 indicating that Biotricity is being referred to more favorably in the news media. Company Overall Sentiment ENDRA Life Sciences Neutral Biotricity Neutral Does the MarketBeat Community favor NDRA or BTCY? ENDRA Life Sciences received 236 more outperform votes than Biotricity when rated by MarketBeat users. Likewise, 62.77% of users gave ENDRA Life Sciences an outperform vote while only 0.00% of users gave Biotricity an outperform vote. CompanyUnderperformOutperformENDRA Life SciencesOutperform Votes23662.77% Underperform Votes14037.23% BiotricityOutperform VotesNo VotesUnderperform Votes2100.00% Do analysts rate NDRA or BTCY? ENDRA Life Sciences currently has a consensus target price of $700,000.00, suggesting a potential upside of 16,166,181.76%. Given ENDRA Life Sciences' stronger consensus rating and higher possible upside, equities research analysts clearly believe ENDRA Life Sciences is more favorable than Biotricity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ENDRA Life Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is NDRA or BTCY more profitable? ENDRA Life Sciences has a net margin of 0.00% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat ENDRA Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets ENDRA Life SciencesN/A -127.39% -103.77% Biotricity -80.42%N/A -188.47% Which has more risk and volatility, NDRA or BTCY? ENDRA Life Sciences has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Which has preferable earnings & valuation, NDRA or BTCY? ENDRA Life Sciences has higher earnings, but lower revenue than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than ENDRA Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioENDRA Life SciencesN/AN/A-$10.06M-$901.150.00Biotricity$12.06M1.31-$14.09M-$1.08-0.60 Do institutionals and insiders hold more shares of NDRA or BTCY? 1.2% of ENDRA Life Sciences shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 0.0% of ENDRA Life Sciences shares are held by company insiders. Comparatively, 10.1% of Biotricity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryENDRA Life Sciences beats Biotricity on 9 of the 17 factors compared between the two stocks. Get ENDRA Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NDRA vs. The Competition Export to ExcelMetricENDRA Life SciencesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.44M$3.37B$5.84B$9.14BDividend YieldN/A1.64%4.75%3.85%P/E Ratio0.0015.9126.0419.11Price / SalesN/A73.24447.4676.36Price / CashN/A44.0938.0134.83Price / Book0.003.857.644.62Net Income-$10.06M$92.00M$3.18B$245.85M7 Day Performance-13.66%4.50%-2.00%-2.61%1 Month Performance-22.68%9.09%-0.44%-2.14%1 Year Performance-100.00%12.27%16.44%12.98% ENDRA Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NDRAENDRA Life Sciences2.3349 of 5 stars$4.33-4.8%$700,000.00+16,166,181.8%-100.0%$2.44MN/A0.0020Gap UpBTCYBiotricityN/A$0.39-3.7%N/A-47.1%$9.58M$12.06M-0.2840News CoveragePOAIPredictive Oncology1.7285 of 5 stars$1.43-1.4%$3.00+109.8%-61.0%$9.53M$1.48M-0.4730AEMDAethlon Medical2.5011 of 5 stars$0.68-6.2%$7.00+930.2%-65.7%$9.49M$570,000.00-0.2410Analyst ForecastAnalyst RevisionINBSIntelligent Bio Solutions0.3388 of 5 stars$2.09-1.4%N/A-45.5%$9.18M$3.11M0.0010News CoverageHigh Trading VolumeNURONeuroMetrix0.4511 of 5 stars$4.38+0.3%N/A+38.5%$8.94M$5.90M-0.9620Positive NewsMHUAMeihua International Medical Technologies0.8348 of 5 stars$0.35+5.2%N/A-53.3%$8.67M$97.10M0.00620CUTRCutera1.4541 of 5 stars$0.43-2.8%$3.00+603.2%-84.1%$8.61M$212.37M-0.06460Analyst ForecastGap UpQTIQT ImagingN/A$0.31-14.7%N/AN/A$8.41M$4.00M0.00N/ANews CoverageGap UpICUSeaStar Medical0.3078 of 5 stars$1.80-8.2%N/A-95.2%$8.03MN/A-0.152PAVMPAVmed4.2877 of 5 stars$0.72+16.0%$19.00+2,541.1%-56.7%$7.96M$4.03M-0.1790News CoverageHigh Trading Volume Related Companies and Tools Related Companies Biotricity Competitors Predictive Oncology Competitors Aethlon Medical Competitors Intelligent Bio Solutions Competitors NeuroMetrix Competitors Meihua International Medical Technologies Competitors Cutera Competitors QT Imaging Competitors SeaStar Medical Competitors PAVmed Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NDRA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NDRA Stock Alerts